Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Adicet Bio Inc (ACET)

Adicet Bio Inc (ACET)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Adicet Bio Inc 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 USA

www.adicetbio.com Employees: 102 P: 650-503-9095

Sector:

Medical

Description:

Adicet Bio Inc. is a biotechnology company. It engages in discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet Bio Inc., formerly known as RESTORBIO INC, is based in Calif.

Key Statistics

Overview:

Market Capitalization, $K 63,912
Enterprise Value, $K 24,992
Shares Outstanding, K 9,596
Float, K 9,155
% Float 95.40%
Short Interest, K 640
Short Float 6.67%
Days to Cover 4.58
Short Volume Ratio 0.42
% of Insider Shareholders 4.60%
% of Institutional Shareholders 83.89%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -116,800 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -30,520 K
EBIT, $ -122,120 K
EBITDA, $ -119,790 K

Growth:

1-Year Return -45.67%
3-Year Return -92.77%
5-Year Return -96.82%
5-Year Revenue Growth -100.00%
5-Year Earnings Growth 78.85%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -2.94 on 03/12/26
Next Earnings Date 05/05/26
Earnings Per Share ttm -17.98
EPS Growth vs. Prev Qtr 36.64%
EPS Growth vs. Prev Year 42.58%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 09/21/18
Dividend Payable Date 10/09/18
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 12/30/25

ACET Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -82.96%
Return-on-Assets % -68.00%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.43
Book Value/Share 16.62
Interest Coverage -2,919.00
60-Month Beta 1.56
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.